224 related articles for article (PubMed ID: 28428618)
1. Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy.
Lin C; Wong BCK; Chen H; Bian Z; Zhang G; Zhang X; Kashif Riaz M; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Sci Rep; 2017 Apr; 7(1):1097. PubMed ID: 28428618
[TBL] [Abstract][Full Text] [Related]
2. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
3. Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
Zhang X; Lin C; Chan W; Liu K; Lu A; Lin G; Hu R; Shi H; Zhang H; Yang Z
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547459
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.
Wong BC; Zhang H; Qin L; Chen H; Fang C; Lu A; Yang Z
Drug Des Devel Ther; 2014; 8():993-1001. PubMed ID: 25092965
[TBL] [Abstract][Full Text] [Related]
5. Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.
Zhu J; Wang H; Chen F; Lv H; Xu Z; Fu J; Hou Y; Xu Y; Pi J
Toxicol Appl Pharmacol; 2018 Nov; 358():1-9. PubMed ID: 30196066
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of anti-carbonic anhydrase IX antibody in hydrogel microspheres for tumor targeting.
Takacova M; Hlouskova G; Zatovicova M; Benej M; Sedlakova O; Kopacek J; Pastorek J; Lacik I; Pastorekova S
J Enzyme Inhib Med Chem; 2016; 31(sup1):110-118. PubMed ID: 27140748
[TBL] [Abstract][Full Text] [Related]
7. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
[TBL] [Abstract][Full Text] [Related]
8. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
[TBL] [Abstract][Full Text] [Related]
9. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain.
Zatovicova M; Jelenska L; Hulikova A; Csaderova L; Ditte Z; Ditte P; Goliasova T; Pastorek J; Pastorekova S
Curr Pharm Des; 2010; 16(29):3255-63. PubMed ID: 20819068
[TBL] [Abstract][Full Text] [Related]
11. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Westfall SD; Nilsson EE; Skinner MK
Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
[TBL] [Abstract][Full Text] [Related]
12. Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
Bryant JL; Gieling RG; Meredith SL; Allen TJ; Walker L; Telfer BA; Supuran CT; Williams KJ; White A
Int J Cancer; 2018 Jan; 142(1):191-201. PubMed ID: 28905987
[TBL] [Abstract][Full Text] [Related]
13. Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts.
Chen C; Yang S; Zhang M; Zhang Z; Hong J; Han D; Ma J; Zhang SB; Okunieff P; Zhang L
Cancer Biol Ther; 2016 Apr; 17(4):381-9. PubMed ID: 27003327
[TBL] [Abstract][Full Text] [Related]
14. The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo.
Yamaguchi A; Usami K; Shimabe M; Hasegawa K; Asada M; Motoki K; Tahara T; Masuda K
Anticancer Res; 2015 Apr; 35(4):1997-2004. PubMed ID: 25862852
[TBL] [Abstract][Full Text] [Related]
15. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
16. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of the monoclonal antibody
Čepa A; Ráliš J; Král V; Paurová M; Kučka J; Humajová J; Lázníček M; Lebeda O
Appl Radiat Isot; 2018 Mar; 133():9-13. PubMed ID: 29272822
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Riaz MK; Zhang X; Wong KH; Chen H; Liu Q; Chen X; Zhang G; Lu A; Yang Z
Int J Nanomedicine; 2019; 14():2879-2902. PubMed ID: 31118613
[No Abstract] [Full Text] [Related]
19. Afatinib-loaded immunoliposomes functionalized with cetuximab: A novel strategy targeting the epidermal growth factor receptor for treatment of non-small-cell lung cancer.
Lu X; Liu S; Han M; Yang X; Sun K; Wang H; Mu H; Du Y; Wang A; Ni L; Zhang C
Int J Pharm; 2019 Apr; 560():126-135. PubMed ID: 30742982
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
